Patents by Inventor Andrew Peter Mallon

Andrew Peter Mallon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biodegradable Implant Including Naltrexone
    Publication number: 20230097377
    Abstract: A formulation of naltrexone that ameliorates undesirable localized reactions at the site of implantation.
    Type: Application
    Filed: April 1, 2022
    Publication date: March 30, 2023
    Inventors: Brady J. Granier, Ashok Kumar, Vitalii E Stelmakh, Robert P Giannini, JR., Andrew Peter Mallon, George Edward Sherman, JR.
  • Methods of Treatment and Prevention of Disease by Arginine-rich Compositions that Induce Cytoprotection and Neuroprotection
    Publication number: 20170114093
    Abstract: The present invention refers to a composition of arginine-rich poly-peptides, compounds and materials and their use in a method for treatment, amelioration or prevention of cell death associated medical conditions by the provision of a protectant therapy, including cytoprotection and neuroprotection.
    Type: Application
    Filed: May 30, 2016
    Publication date: April 27, 2017
    Inventor: Andrew Peter Mallon
  • Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
    Publication number: 20140296164
    Abstract: The present invention describes peptide drugs that inhibit the interaction between CAL and CFTR, and other proteins in cystic fibrosis and other diseases. These invented drugs have been chemically optimized to impart solubility, stability, cell permeability, mucus penetration, intracellular targeting and sequestration, increased potency and non-immunogenicity, while conserving and imparting efficacy. This renders these compositions suitable for human use, which is exemplified by use in the treatment of cystic fibrosis.
    Type: Application
    Filed: March 29, 2014
    Publication date: October 2, 2014
    Applicant: CALISTA THERAPEUTICS, INC.
    Inventors: Andrew Peter Mallon, Alvin C. Bach, II